Cargando…
Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108855/ http://dx.doi.org/10.1186/1479-5876-12-S1-O8 |
| _version_ | 1782327797474131968 |
|---|---|
| author | Postow, Michael A Cardona, Diana M Taube, Janis M Anders, Robert A Taylor, Clive R Wolchok, Jedd D Callahan, Margaret K Curran, Michael A Lesokhin, Alexander M Grosso, Joseph F Horak, Christine E Cogswell, John Simon, Jason S Gupta, Ashok K Sznol, Mario |
| author_facet | Postow, Michael A Cardona, Diana M Taube, Janis M Anders, Robert A Taylor, Clive R Wolchok, Jedd D Callahan, Margaret K Curran, Michael A Lesokhin, Alexander M Grosso, Joseph F Horak, Christine E Cogswell, John Simon, Jason S Gupta, Ashok K Sznol, Mario |
| author_sort | Postow, Michael A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4108855 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41088552014-08-04 Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab Postow, Michael A Cardona, Diana M Taube, Janis M Anders, Robert A Taylor, Clive R Wolchok, Jedd D Callahan, Margaret K Curran, Michael A Lesokhin, Alexander M Grosso, Joseph F Horak, Christine E Cogswell, John Simon, Jason S Gupta, Ashok K Sznol, Mario J Transl Med Oral Presentation BioMed Central 2014-05-06 /pmc/articles/PMC4108855/ http://dx.doi.org/10.1186/1479-5876-12-S1-O8 Text en Copyright © 2014 Postow et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Postow, Michael A Cardona, Diana M Taube, Janis M Anders, Robert A Taylor, Clive R Wolchok, Jedd D Callahan, Margaret K Curran, Michael A Lesokhin, Alexander M Grosso, Joseph F Horak, Christine E Cogswell, John Simon, Jason S Gupta, Ashok K Sznol, Mario Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab |
| title | Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab |
| title_full | Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab |
| title_fullStr | Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab |
| title_full_unstemmed | Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab |
| title_short | Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab |
| title_sort | peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-pd-1, bms-936558, ono-4538) monotherapy or in combination with ipilimumab |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108855/ http://dx.doi.org/10.1186/1479-5876-12-S1-O8 |
| work_keys_str_mv | AT postowmichaela peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT cardonadianam peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT taubejanism peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT andersroberta peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT taylorcliver peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT wolchokjeddd peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT callahanmargaretk peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT curranmichaela peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT lesokhinalexanderm peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT grossojosephf peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT horakchristinee peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT cogswelljohn peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT simonjasons peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT guptaashokk peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab AT sznolmario peripheralandtumorimmunecorrelatesinpatientswithadvancedmelanomatreatedwithnivolumabantipd1bms936558ono4538monotherapyorincombinationwithipilimumab |